Quality measures of antimicrobial drug use

被引:73
作者
Gyssens, IC [1 ]
机构
[1] Erasmus Univ, Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, NL-3000 CA Rotterdam, Netherlands
关键词
antibiotics; antibiotic policy; antibiotic resistance; quality; audit;
D O I
10.1016/S0924-8579(00)00208-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial use is the major determinant in the development of resistance. Many parameters of importance for optimal quality of antimicrobial therapy have already been defined. Maximal efficacy of the treatment should be combined with minimal toxicity at the lowest cost. Quality of antimicrobial drug use is dependent on knowledge of many aspects of infectious diseases. Considering efficacy, many of our indications for antimicrobial use need critical evaluation. Irrational use should be discouraged. Avoidance of the development of resistance is a quality parameter that will need increasing attention. This paper reviews the well-established factors that may influence the appropriateness of pharmacotherapy with antimicrobial drugs. It cites recent evidence supporting principles of prudent prescribing and gives an overview of audits that have addressed these parameters. Measures relating to resistance are discussed. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 124 条
[1]   The efficacy of routine outpatient management without antibiotics of fever in selected infants [J].
Baker, MD ;
Bell, LM ;
Avner, JR .
PEDIATRICS, 1999, 103 (03) :627-631
[2]   Parents, physicians, and antibiotic use [J].
Bauchner, H ;
Pelton, SI ;
Klein, JO .
PEDIATRICS, 1999, 103 (02) :395-401
[3]   Strategies for promoting judicious use of antibiotics by doctors and patients [J].
Belongia, EA ;
Schwartz, B .
BRITISH MEDICAL JOURNAL, 1998, 317 (7159) :668-671
[4]   Antibiotics in acute bronchitis: A meta-analysis [J].
Bent, S ;
Saint, S ;
Vittinghoff, E ;
Grady, D .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (01) :62-67
[5]  
BONTEN M, 2000, IN PRESS J ANTIMICRO
[6]   MULTIDISCIPLINARY COST-CONTAINMENT PROGRAM PROMOTING ORAL METRONIDAZOLE FOR TREATMENT OF ANTIBIOTIC-ASSOCIATED COLITIS [J].
BRICELAND, LL ;
QUINTILIANI, R ;
NIGHTINGALE, CH .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (01) :122-125
[7]   Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].
Byl, B ;
Clevenbergh, P ;
Jacobs, F ;
Struelens, MJ ;
Zech, F ;
Kentos, A ;
Thys, JP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66
[8]   Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents [J].
Carmeli, Y ;
Troillet, N ;
Eliopoulos, GM ;
Samore, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1379-1382
[9]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V29, P405
[10]   Contributors to antibiotic resistance - Antibiotics should not be first treatment for acne [J].
Cheesbrough, MJ .
BRITISH MEDICAL JOURNAL, 1999, 318 (7184) :669-669